REBECCA BIRD: Open Payments
NPI 1184166522 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 49 payments from 20 companies in 2025. Trend: 2023 $520 · 2024 $1,225 · 2025 $1,591
Food & beverage: $1,406Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $333 |
| Stemline Therapeutics Inc. | 5 | $177 |
| Incyte Corporation | 3 | $155 |
| GENZYME CORPORATION | 2 | $143 |
| Coherus Oncology, Inc. | 5 | $121 |
| SOBI, INC | 2 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Merck Sharp & Dohme LLC | 3 | $70 |
| Gilead Sciences, Inc. | 3 | $69 |
Products named: Orserdu, JAKAFI, RYBREVANT, LOQTORZI, DARZALEX, WAYRILZ, KEYTRUDA, Trodelvy.
Industry payments across FL — which companies pay providers there.
